Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP809075.RAS1pq0eCU8biIAJI7u1DxS2OswxzkIjscNYUW5Euw0EU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP809075.RAS1pq0eCU8biIAJI7u1DxS2OswxzkIjscNYUW5Euw0EU130_assertion type Assertion NP809075.RAS1pq0eCU8biIAJI7u1DxS2OswxzkIjscNYUW5Euw0EU130_head.
- NP809075.RAS1pq0eCU8biIAJI7u1DxS2OswxzkIjscNYUW5Euw0EU130_assertion wasGeneratedBy ECO_0000203 NP809075.RAS1pq0eCU8biIAJI7u1DxS2OswxzkIjscNYUW5Euw0EU130_provenance.
- NP809075.RAS1pq0eCU8biIAJI7u1DxS2OswxzkIjscNYUW5Euw0EU130_assertion wasDerivedFrom befree-20150227 NP809075.RAS1pq0eCU8biIAJI7u1DxS2OswxzkIjscNYUW5Euw0EU130_provenance.
- NP809075.RAS1pq0eCU8biIAJI7u1DxS2OswxzkIjscNYUW5Euw0EU130_assertion SIO_000772 21703428 NP809075.RAS1pq0eCU8biIAJI7u1DxS2OswxzkIjscNYUW5Euw0EU130_provenance.
- NP809075.RAS1pq0eCU8biIAJI7u1DxS2OswxzkIjscNYUW5Euw0EU130_assertion evidence source_evidence_literature NP809075.RAS1pq0eCU8biIAJI7u1DxS2OswxzkIjscNYUW5Euw0EU130_provenance.
- NP809075.RAS1pq0eCU8biIAJI7u1DxS2OswxzkIjscNYUW5Euw0EU130_assertion description "[We identify the PAR1-ERK1/2 pathway as a feasible target for therapy in lung cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP809075.RAS1pq0eCU8biIAJI7u1DxS2OswxzkIjscNYUW5Euw0EU130_provenance.